10:40:18 Europe / Stockholm

Prenumeration

2023-03-02 07:20:00

Redeye retains its positive view on Efecte, following a Q4 report with high growth from new sales, boosting overall MRR growth, being the highlight. Despite macroeconomic uncertainties, Efecte guides for +20% SaaS revenue growth in 2023, expecting the strong contribution from new sales to continue. We expect Efecte to continue to perform in line with its 2025 targets.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/